Melbourne, Victoria, Australia–(Newsfile Corp. – March 17, 2025) – Besra Gold Inc. (ASX: BEZ) (“Besra” or the “Company”) refers to the ASX letter dated 17 March 2025 and responds to questions. You can click the link below to read this announcement in full. https://www.besra.com/17-3-2025-bez-response-to-asx-price-query/ About Besra – www.besra.com Besra is …
Read More »Penbar Capital Ltd. Announces Proposed Qualifying Transaction
Vancouver, British Columbia–(Newsfile Corp. – March 17, 2025) – Penbar Capital Ltd. (TSXV: PEM.P) (the “Company”) is pleased to announce that it has entered into a definitive amalgamation agreement (the “Definitive Agreement”) on March 14, 2025, with Eastport Ventures Inc. (“Eastport”), an arm’s length party, pursuant to which the Company …
Read More »Avalanche Joins TheBlock as the First Apex Member in Dubai
Dubai, United Arab Emirates–(Newsfile Corp. – March 17, 2025) – Dubai is rapidly emerging as a global leader in blockchain and digital assets, with TheBlock playing a pivotal role in this transformation. In a significant milestone, Avalanche has become the first Apex member of TheBlock, marking a key development in …
Read More »Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
Calgary, Alberta–(Newsfile Corp. – March 17, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or “HEM”), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, pitched the treatment of Vascular Dementia with ACP-01 to Wall Street. “The specificity …
Read More »Greenbriar Completes Major Water Acquisition for Sage Ranch
Scottsdale, Arizona–(Newsfile Corp. – March 17, 2025) – Greenbriar Sustainable Living Inc. (TSXV: GRB) (OTC Pink: GEBRF) (“Greenbriar” or the “Company”) is pleased to announce that it has reached a binding agreement with Ronnie Strasser to buy 115 acre-feet of adjudicated and deeded water rights for USD $1,250,000. With this …
Read More »Data I/O to Demonstrate New Unified Programming Platform Strategy at the Upcoming IPC APEX Expo
Newly refreshed manual programmers engineered to seamlessly support design through production and beyond on a single platform Redmond, Washington–(Newsfile Corp. – March 17, 2025) – Data I/O Corporation (NASDAQ: DAIO), the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, announced the …
Read More »Searchlight Resources Stakes in the Athabasca Basin
New Staking in Eastern Athabasca Basin2 new claims covering 3,902.8 hectares (39.0 sq km)Within 2 km of anomalous uranium and REE drill holesClose to road and electrical infrastructure Vancouver, British Columbia–(Newsfile Corp. – March 17, 2025) – Searchlight Resources Inc. (TSXV: SCLT) (OTC Pink: SCLTF) (“Searchlight” or the “Company”) is pleased …
Read More »SuperBuzz Announces TSXV Approval of Consolidation
Toronto, Ontario–(Newsfile Corp. – March 17, 2025) – SuperBuzz Inc. (TSXV: SPZ) (“SuperBuzz” or the “Company”), is pleased to announce that further to its press release dated November 26, 2024, and December 24, 2024, the TSX Venture Exchange (the “Exchange”) has approved the consolidation of the Company’s issued and outstanding …
Read More »Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Seek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage White Bear Lake, Minnesota–(Newsfile Corp. – March 17, 2025) – Envoy Medical®, Inc. (NASDAQ: COCH) (“Envoy Medical”), a revolutionary hearing health company focused on fully implanted …
Read More »Pacylex Pharmaceuticals Announces the First Acute Myeloid Leukemia (AML) Patient Dosed with Zelenirstat In a New Phase 1/2 Clinical Trial
Edmonton, Alberta–(Newsfile Corp. – March 17, 2025) – Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under clinical investigation as a first-in-class targeted therapy for the treatment of hematologic cancers. Pacylex has 27 additional potent NTMis …
Read More »
Matribhumi Samachar English